Minia University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Minya Egypt (1976)

Organization Overview

First Clinical Trial
2013
NCT01841411
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Ahmad Elheeny | Al-Menia Univeristy Hospital | Alshimaa Nasser Mahmoud | Anesthesia and ICU department, Faculty of Medicine, Minia University | Associate professor of Pharmaceutics, Faculty of Pharmacy, Minia and Deray University, Minia, Egypt. | Dean of Faculty | Dr Haidy Salah | Dr Wegdan Ali Abdelrahman | El Minia University | Faculty of Dentistry, Minia University | Faculty of medicine. ElMinia University | Faculty of medicine Minia university | Faculty of Medicine, Minia University | Faulty of medicine, Minia University | Hassan Mokhtar Elshorbagy Hetta | Lecturer at Faculty of Dentistry Minia University | Lecturer of Biomechanics, Faculty of Physical Therapy, Deraya University, Minia, | lecturer of orthodontics, Minia University | Mahmoud Ahmed Mahmoud | Mina university hospital | Minia faculty of Medicine. Minia university. Egypt | Minia Universiry hospital | Minia University | Minia University and SFH | minia university/ faculty of medicine | Minia university hopital of gynecology and obstetrics | minia university hospital | Minia University Hospital | ophthalmology department, faculty of medicine, Minia university hospital | oral medicine and periodontology department faculty of dentistry minia university | Pediatric Dentistry Department, Faculty of Dentistry, Minia University | Professor of Anesthesia and intensive care, MiniaU. | Sara Botros

Active Ingredients

Drugs in Phase 4 Trials (15)

acetylcysteine (mucomyst) (1 trial)

aflibercept (zaltrap) (1 trial)

human choriogonadotropin alfa (hCG) (1 trial)

ketamine (ketalar) (3 trials)

letrozole (femara) (1 trial)

leuprolide (lupron) (1 trial)

menopausal gonadotropin (1 trial)

metformin (glucophage) (2 trials)

metronidazole (flagyl) (1 trial)

polyglactin 910 (1 trial)

ranibizumab (lucentis) (1 trial)

saffron (1 trial)

sitagliptin (januvia) (2 trials)

triclosan (1 trial)

vildagliptin (1 trial)

Drugs in Phase 3 Trials (6)

clonidine (catapres) (1 trial)

ethanol (1 trial)

pentoxifylline (trental) (1 trial)

platelet-rich plasma (2 trials)

propylene glycol (1 trial)

urofollitropin (Metrodin) (1 trial)

Drugs in Phase 2 Trials (18)

acetaminophen (tylenol) (1 trial)

articaine (Septocaine) (3 trials)

bupivacaine (Exparel) (5 trials)

epinephrine (levophed) (4 trials)

insulin human (humulin) (3 trials)

itraconazole (sporanox) (1 trial)

lidocaine (xylocaine) (6 trials)

magnesium sulfate (Tis-U-Sol) (2 trials)

Menotropin (Menopur) (1 trial)

morphine (2 trials)

multivitamins (1 trial)

nalbuphine (nubain) (2 trials)

nitroglycerin (transderm-nitro) (1 trial)

plasma rich in growth factors (2 trials)

pregabalin (lyrica) (1 trial)

rgd peptide (1 trial)

risperidone (risperdal) (1 trial)

voriconazole (vfend) (1 trial)

Drugs in Phase 1 Trials (16)

atorvastatin (lipitor) (1 trial)

dexmedetomidine (precedex) (7 trials)

gabapentin (neurontin) (1 trial)

hyaluronic acid (1 trial)

hyaluronidase (bovine) (Wydase) (2 trials)

hydroxyzine (vistaril) (1 trial)

melatonin (1 trial)

methotrexate (1 trial)

midazolam (versed) (3 trials)

moringa oleifera (1 trial)

olive (1 trial)

oxiconazole (oxistat) (1 trial)

progesterone (progestasert) (2 trials)

propranolol (inderal) (1 trial)

simvastatin (zocor) (1 trial)

triamcinolone (kenalog) (1 trial)

Drugs in Other Trials (25)

benzocaine (Orajel) (1 trial)

calcium hydroxide (1 trial)

chitosan (1 trial)

concentrated growth factor (1 trial)

dexamethasone (2 trials)

doxycycline (vibramycin) (1 trial)

fentanyl (Innovar) (1 trial)

galla chinensis (1 trial)

garlic (1 trial)

hexametaphosphate (2 trials)

hypochlorous acid (1 trial)

levobupivacaine (chirocaine) (1 trial)

levonordefrin (Neo-Cobefrine) (1 trial)

memantine (namenda) (1 trial)

mepivacaine (carbocaine) (1 trial)

methylcellulose (1 trial)

methylprednisolone (medrol) (1 trial)

naltrexone (revia) (1 trial)

ozone (1 trial)

povidone-iodine (betadine) (1 trial)

prilocaine (citanest) (1 trial)

silver nanoparticles (2 trials)

tin difluoride (1 trial)

vitamin d3 (1 trial)

vitamin k (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Autism Spectrum Disorder (Phase 2)

Autistic Disorder (Phase 2)

Azoospermia (Phase 3)

Brain Edema (Phase 1)

Brain Injuries (Phase 1)

Brain Injuries, Traumatic (Phase 1)

Brain Neoplasms (Phase 1)

Communicable Diseases (Phase 4)

Diabetes, Gestational (Phase 3)

Edema (Phase 4)

Hemorrhage (Phase 1)

Infections (Phase 4)

Infertility (Phase 4)

Macular Edema (Phase 4)

Olfaction Disorders (Phase 2)

Pain, Postoperative (Phase 2)

Postoperative Nausea and Vomiting (Phase 2)

Pruritus (Phase 2)

Surgical Wound (Phase 4)

Surgical Wound Infection (Phase 4)

Tinea Versicolor (Phase 2)

Vaginal Diseases (Phase 4)

Vaginosis, Bacterial (Phase 4)

Vomiting (Phase 2)

Wound Infection (Phase 4)

Wounds and Injuries (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 68
  • # of Trial APIs: 80